Evenamide structure
|
Common Name | Evenamide | ||
|---|---|---|---|---|
| CAS Number | 1092977-61-1 | Molecular Weight | 278.390 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 412.1±30.0 °C at 760 mmHg | |
| Molecular Formula | C16H26N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 203.0±24.6 °C | |
Use of EvenamideEvenamide (NW-3509), a sodium channel blocker, shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness[1]. |
| Name | Evenamide |
|---|---|
| Synonym | More Synonyms |
| Description | Evenamide (NW-3509), a sodium channel blocker, shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness[1]. |
|---|---|
| Target |
Sodium channel[1] |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 412.1±30.0 °C at 760 mmHg |
| Molecular Formula | C16H26N2O2 |
| Molecular Weight | 278.390 |
| Flash Point | 203.0±24.6 °C |
| Exact Mass | 278.199432 |
| LogP | 2.38 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.510 |
| N2-[2-(3-Butoxyphenyl)ethyl]-N,N-dimethylglycinamide |
| NW-3509 |
| Acetamide, 2-[[2-(3-butoxyphenyl)ethyl]amino]-N,N-dimethyl- |
| Evenamide |
| NW-3509A |
| ON5S6N53JS |
| MFCD28502433 |